By Letara Draghia
Copyright euroweeklynews
The Andalusian Ministry of Health and Consumer Affairs will launch its third immunisation campaign against bronchiolitis on Monday, September 22, targeting babies under six months of age.
The region expects to vaccinate 60,000 infants with nirsevimab, following last year’s record 95.3 per cent coverage rate that reduced hospitalisations by 80 per cent.
RSV: a leading cause of bronchiolitis in infants
Respiratory syncytial virus (RSV) is the main cause of bronchiolitis, a respiratory infection that inflames tiny airways in the lungs, making it difficult for infants to breathe. According to KidsHealth, symptoms start like a cold but can worsen to wheezing or severe breathing problems, sometimes requiring hospitalisation.
RSV infections peak during autumn and winter, with babies under six months, premature infants, and children with chronic health conditions most at risk.
Who will be vaccinated in Andalucia
Parents of babies born from April 1, 2025, are now being contacted for appointments, while those born between September 22, 2025, and March 31, 2026, will be vaccinated in maternity wards before discharge.
In addition, immunisation will be offered to:
Infants under one year born prematurely (under 35 weeks)
Children under two years with serious chronic conditions
For the 2025–2026 campaign, 73,000 doses of nirsevimab have been purchased with a €15.8 million budget.
Andalucia introduced RSV immunisation in 2023. In the 2024–2025 season, more than 55,000 infants were vaccinated, achieving 95.3 per cent coverage. As a result, bronchiolitis-related hospital admissions in children fell by around 2,000 cases, an 80 per cent reduction compared to previous years.
Health officials stress that the vaccine is both safe and effective in preventing serious illness. Parents are urged to accept the immunisation invitation to protect infants during the high-risk winter season.
Why the bronchiolitis vaccine matters for expats in Andalucia
For expat families raising young children in the region, the campaign offers access to one of the most advanced RSV prevention programmes in Europe. It ensures that babies can be protected early, reducing the risk of hospitalisation and easing pressures on both families and the Spanish healthcare system.
View all news from the Costa del Sol.
View all health news.